PROFOUND MEDICAL CORP (PRN.CA) Forecast, Price Target & Analyst Ratings
TSX:PRN • CA74319B5027
7.08 CAD
-2.92 (-29.2%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PROFOUND MEDICAL CORP (PRN.CA).
Forecast Snapshot
Consensus Price Target
CA$15.56
+ 119.70% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.25
Revenue Estimate6.666M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$15.56
Upside
+ 119.70%
From current price of CA$7.08 to mean target of CA$15.56, Based on 5 analyst forecasts
Low
CA$15.40
Median
CA$15.56
High
CA$16.01
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
5 analysts have analysed PRN.CA and the average price target is 15.56 CAD. This implies a price increase of 119.7% is expected in the next year compared to the current price of 7.08.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PRN.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PRN.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed PRN.CA. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-03-07 | Cown | Initiate | Buy |
| 2022-02-22 | Raymond James Capital | Initiate | Buy |
| 2022-02-22 | Raymond James Financial | Initiate | Buy |
| 2021-10-27 | Raymond James Financial | Downgrade | Strong Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.25
Revenue Estimate6.666M
Revenue Q2Q154.33%
EPS Q2Q29.86%
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
-3.57%
Revenue (3 Months)
-3.57%
EPS (1 Month)
4.76%
EPS (3 Months)
4.76%
Next Earnings Summary
PRN.CA is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.25 CAD and the consensus revenue estimate is 6.67M CAD.
The next earnings revenue estimate has been revised downward by 3.57% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.681M -2.79% | 7.199M 7.75% | 10.68M 48.35% | 17.237M 61.40% | 34.677M 101.18% | 55.702M 60.63% | 78.446M 40.83% | 194.58M 148.04% | 265.02M 36.20% | 333.85M 25.97% | 411.57M 23.28% | 498.56M 21.14% | |
| EBITDA YoY % growth | -27.998M 1.46% | -27.47M 1.89% | -32.126M -16.95% | -37.269M -16.01% | -29.24M 21.54% | -14.342M 50.95% | 26.768M 286.64% | 71.993M 168.95% | 109.98M 52.76% | 143.56M 30.53% | 181.09M 26.14% | 229.34M 26.64% | |
| EBIT YoY % growth | -29.602M 2.27% | -28.616M 3.33% | -33.062M -15.54% | -43.06M -30.24% | -34.475M 19.94% | -21.816M 36.72% | -1.918M 91.21% | 12.216M 736.82% | 32.464M 165.75% | N/A | N/A | N/A | |
| Operating Margin | -443.08% | -397.50% | -309.57% | -249.81% | -99.42% | -39.17% | -2.45% | 6.28% | 12.25% | N/A | N/A | N/A | |
| EPS YoY % growth | -1.38 8.00% | -1.35 2.17% | -1.12 17.04% | -1.44 -25.89% | -1.08 23.59% | -0.69 36.25% | -0.07 89.72% | 1.34 1,992.27% | 2.06 54.06% | 2.70 31.36% | 3.42 26.50% | 5.22 52.63% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 29.86% | -0.24 54.36% | -0.22 14.54% | -0.20 27.06% | -0.20 20.00% | -0.12 48.94% | -0.06 72.73% | 0.00 100.00% |
| Revenue Q2Q % growth | 6.666M 154.33% | 8.383M 279.15% | 9.797M 85.23% | 11.009M 84.10% | 12.387M 85.82% | 14.738M 75.81% | 17.357M 77.17% | 20.241M 83.86% |
| EBITDA Q2Q % growth | -7.272M 33.91% | -3.333M 75.31% | -2.828M 66.58% | -7.479M -10.52% | -5.942M 18.29% | -3.502M -5.06% | -1.633M 42.25% | 400.97K 105.36% |
| EBIT Q2Q % growth | -9.444M 15.43% | -7.828M 43.30% | -7.323M 17.84% | -6.565M 22.92% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
14.80%
EPS Next 5 Year
22.30%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
75.58%
Revenue Next 5 Year
67.22%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.34%
EBIT Next 5 Year
28.78%
PROFOUND MEDICAL CORP / PRN.CA Forecast FAQ
What is the average price target for PROFOUND MEDICAL CORP (PRN.CA) stock?
5 analysts have analysed PRN.CA and the average price target is 15.56 CAD. This implies a price increase of 119.7% is expected in the next year compared to the current price of 7.08.
When does PROFOUND MEDICAL CORP (PRN.CA) report earnings?
PROFOUND MEDICAL CORP (PRN.CA) will report earnings on 2026-05-06.
What are the consensus estimates for PRN stock next earnings?
The consensus EPS estimate for the next earnings of PROFOUND MEDICAL CORP (PRN.CA) is -0.25 CAD and the consensus revenue estimate is 6.67M CAD.
What is the expected long term growth rate for PRN stock?
The expected long term growth rate for PROFOUND MEDICAL CORP (PRN.CA) is 75.58%.